BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23355743)

  • 1. Clinical evidence for the role of Trichomonas vaginalis in regulation of secretory leukocyte protease inhibitor in the female genital tract.
    Huppert JS; Huang B; Chen C; Dawood HY; Fichorova RN
    J Infect Dis; 2013 May; 207(9):1462-70. PubMed ID: 23355743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between secretory leukocytic protease inhibitor and reactive nitrogen intermediates levels in cervicovaginal secretions from symptomatic and asymptomatic trichomoniasis Egyptians patients.
    Al-Mohammed HI; Hussein EM
    J Egypt Soc Parasitol; 2006 Dec; 36(3):763-77. PubMed ID: 17153694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant cervical innate immunity predicts onset of dysbiosis and sexually transmitted infections in women of reproductive age.
    Fichorova RN; Morrison CS; Chen PL; Yamamoto HS; Govender Y; Junaid D; Ryan S; Kwok C; Chipato T; Salata RA; Doncel GF
    PLoS One; 2020; 15(1):e0224359. PubMed ID: 31914129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The villain team-up or how Trichomonas vaginalis and bacterial vaginosis alter innate immunity in concert.
    Fichorova RN; Buck OR; Yamamoto HS; Fashemi T; Dawood HY; Fashemi B; Hayes GR; Beach DH; Takagi Y; Delaney ML; Nibert ML; Singh BN; Onderdonk AB
    Sex Transm Infect; 2013 Sep; 89(6):460-6. PubMed ID: 23903808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteine proteases of Trichomonas vaginalis degrade secretory leukocyte protease inhibitor.
    Draper D; Donohoe W; Mortimer L; Heine RP
    J Infect Dis; 1998 Sep; 178(3):815-9. PubMed ID: 9728551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lower genital tract microbiota in relation to cytokine-, SLPI- and endotoxin levels: application of checkerboard DNA-DNA hybridization (CDH).
    Nikolaitchouk N; Andersch B; Falsen E; Strömbeck L; Mattsby-Baltzer I
    APMIS; 2008 Apr; 116(4):263-77. PubMed ID: 18397461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception.
    Fichorova RN; Chen PL; Morrison CS; Doncel GF; Mendonca K; Kwok C; Chipato T; Salata R; Mauck C
    mBio; 2015 Sep; 6(5):e00221-15. PubMed ID: 26330510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human epididymis protein 4 and secretory leukocyte protease inhibitor in vaginal fluid: relation to vaginal components and bacterial composition.
    Orfanelli T; Jayaram A; Doulaveris G; Forney LJ; Ledger WJ; Witkin SS
    Reprod Sci; 2014 Apr; 21(4):538-42. PubMed ID: 24023032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced levels of genital tract immune biomarkers in postmenopausal women: implications for HIV acquisition.
    Jais M; Younes N; Chapman S; Cu-Uvin S; Ghosh M
    Am J Obstet Gynecol; 2016 Sep; 215(3):324.e1-324.e10. PubMed ID: 27026477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher vaginal pH in Trichomonas vaginalis infection with intermediate Nugent score in reproductive-age women-a hospital-based cross-sectional study in Odisha, India.
    Das P; Swain T; Mohanty JR; Sinha S; Padhi B; Torondel B; Cumming O; Panda B; Nayak A; Panigrahi P
    Parasitol Res; 2018 Sep; 117(9):2735-2742. PubMed ID: 29936622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of an immunochromatographic assay for rapid detection of Trichomonas vaginalis in vaginal specimens.
    Huppert JS; Batteiger BE; Braslins P; Feldman JA; Hobbs MM; Sankey HZ; Sena AC; Wendel KA
    J Clin Microbiol; 2005 Feb; 43(2):684-7. PubMed ID: 15695664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short communication: genital tumor growth factor-β1 levels in HIV-infected Indian women are associated with reduced levels of innate antimicrobial products and increased HIV shedding.
    Thakar M; Patil R; Shukre S; Bichare S; Kadam P; Khopkar P; Ghate M; Paranjape R
    AIDS Res Hum Retroviruses; 2014 Jul; 30(7):648-53. PubMed ID: 24547777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trichomonas vaginalis infection induces vaginal CD4+ T-cell infiltration in a mouse model: a vaccine strategy to reduce vaginal infection and HIV transmission.
    Smith JD; Garber GE
    J Infect Dis; 2015 Jul; 212(2):285-93. PubMed ID: 25616405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary studies on target antigens for the diagnosis of Trichomonas vaginalis infection.
    Deng HY; Lee JC; Chou SC; Wang GR
    J Microbiol Immunol Infect; 1999 Mar; 32(1):14-20. PubMed ID: 11561565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorimetric one-tube nested PCR for detection of Trichomonas vaginalis in vaginal discharge.
    Shaio MF; Lin PR; Liu JY
    J Clin Microbiol; 1997 Jan; 35(1):132-8. PubMed ID: 8968894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pregnancy and bacterial vaginosis on proinflammatory cytokine and secretory leukocyte protease inhibitor concentrations in vaginal secretions.
    Balkus J; Agnew K; Lawler R; Mitchell C; Hitti J
    J Pregnancy; 2010; 2010():385981. PubMed ID: 21490741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution and factors associated with salivary secretory leukocyte protease inhibitor concentrations.
    Rahman S; Pierce Campbell CM; Torres BN; O'Keefe MT; Ingles DJ; Villa LL; Carvalho da Silva RJ; Cintra RC; Lazcano-Ponce E; Salmeron J; Quiterio M; Giuliano AR
    Oral Dis; 2016 Nov; 22(8):781-790. PubMed ID: 27470907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretory leukocyte protease inhibitor levels in cervicovaginal secretion of elderly women.
    Shimoya K; Zhang Q; Temma K; Kimura T; Tsujie T; Tsutsui T; Wasada K; Kanzaki T; Koyama M; Murata Y
    Maturitas; 2006 May; 54(2):141-8. PubMed ID: 16289563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trichomonas vaginalis infection and the diagnostic significance of detection tests among Ghanaian outpatients.
    Asmah RH; Agyeman RO; Obeng-Nkrumah N; Blankson H; Awuah-Mensah G; Cham M; Asare L; Ayeh-Kumi PF
    BMC Womens Health; 2018 Dec; 18(1):206. PubMed ID: 30591043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial vaginosis-associated vaginal microbiota is an age-independent risk factor for Chlamydia trachomatis, Mycoplasma genitalium and Trichomonas vaginalis infections in low-risk women, St. Petersburg, Russia.
    Shipitsyna E; Khusnutdinova T; Budilovskaya O; Krysanova A; Shalepo K; Savicheva A; Unemo M
    Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1221-1230. PubMed ID: 32036466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.